Moreover, certain cDC2s, upon acquiring an interferon-stimulating gene (ISG) activation state (ISG+ DCs), are able to MHC-dress with tumor-derived pMHC-1, stimulate CD8 T cells ex vivo, and drive tumor control even in the absence of cDC1 (75). This evidence concerns the gene HLA-C and neoplasm.